Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment

Johannes Vieweg, Eli Gilboa

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Limited efficacy of chemotherapy in most solid tumors has revived interest in immunotherapeutic approaches for cancer. One novel form of immunotherapy is the use of cancer vaccines consisting of tumor cells genetically engineered to secrete cytokines. The rationale for this immunization strategy is based on the existence of tumor-specific antigens, on the importance of the cellular arm of the immune system in mediating an effective antitumor response, and on the role of cytokines in regulating the cellular immune response. Such tumor vaccines showed considerable promise in various animal models and induced potent antitumor immunity in the host, which led to regression of established tumors and, moreover, produced immunological memory protecting animals from a subsequent tumor challenge at a distant site. Translated to the human patient, this implies that genetically modified tumor vaccines may be able to eradicate or reduce existing tumor deposits to subclinical levels as well as provide long-term protection from regrowth of tumor cells. This report will review and discuss the concept and rationale for the use of cytokine-secreting tumor vaccines for the treatment of human malignancies.

Original languageEnglish
Pages (from-to)193-201
Number of pages9
JournalCancer Investigation
Volume13
Issue number2
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Cytokines
Cancer Vaccines
Neoplasms
Therapeutics
Immunologic Memory
Neoplasm Antigens
Cellular Immunity
Immunotherapy
Immune System
Immunity
Immunization
Animal Models
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment. / Vieweg, Johannes; Gilboa, Eli.

In: Cancer Investigation, Vol. 13, No. 2, 01.01.1995, p. 193-201.

Research output: Contribution to journalArticle

@article{d080d7615fcd43808df858c94c287035,
title = "Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment",
abstract = "Limited efficacy of chemotherapy in most solid tumors has revived interest in immunotherapeutic approaches for cancer. One novel form of immunotherapy is the use of cancer vaccines consisting of tumor cells genetically engineered to secrete cytokines. The rationale for this immunization strategy is based on the existence of tumor-specific antigens, on the importance of the cellular arm of the immune system in mediating an effective antitumor response, and on the role of cytokines in regulating the cellular immune response. Such tumor vaccines showed considerable promise in various animal models and induced potent antitumor immunity in the host, which led to regression of established tumors and, moreover, produced immunological memory protecting animals from a subsequent tumor challenge at a distant site. Translated to the human patient, this implies that genetically modified tumor vaccines may be able to eradicate or reduce existing tumor deposits to subclinical levels as well as provide long-term protection from regrowth of tumor cells. This report will review and discuss the concept and rationale for the use of cytokine-secreting tumor vaccines for the treatment of human malignancies.",
author = "Johannes Vieweg and Eli Gilboa",
year = "1995",
month = "1",
day = "1",
doi = "10.3109/07357909509011690",
language = "English",
volume = "13",
pages = "193--201",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment

AU - Vieweg, Johannes

AU - Gilboa, Eli

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Limited efficacy of chemotherapy in most solid tumors has revived interest in immunotherapeutic approaches for cancer. One novel form of immunotherapy is the use of cancer vaccines consisting of tumor cells genetically engineered to secrete cytokines. The rationale for this immunization strategy is based on the existence of tumor-specific antigens, on the importance of the cellular arm of the immune system in mediating an effective antitumor response, and on the role of cytokines in regulating the cellular immune response. Such tumor vaccines showed considerable promise in various animal models and induced potent antitumor immunity in the host, which led to regression of established tumors and, moreover, produced immunological memory protecting animals from a subsequent tumor challenge at a distant site. Translated to the human patient, this implies that genetically modified tumor vaccines may be able to eradicate or reduce existing tumor deposits to subclinical levels as well as provide long-term protection from regrowth of tumor cells. This report will review and discuss the concept and rationale for the use of cytokine-secreting tumor vaccines for the treatment of human malignancies.

AB - Limited efficacy of chemotherapy in most solid tumors has revived interest in immunotherapeutic approaches for cancer. One novel form of immunotherapy is the use of cancer vaccines consisting of tumor cells genetically engineered to secrete cytokines. The rationale for this immunization strategy is based on the existence of tumor-specific antigens, on the importance of the cellular arm of the immune system in mediating an effective antitumor response, and on the role of cytokines in regulating the cellular immune response. Such tumor vaccines showed considerable promise in various animal models and induced potent antitumor immunity in the host, which led to regression of established tumors and, moreover, produced immunological memory protecting animals from a subsequent tumor challenge at a distant site. Translated to the human patient, this implies that genetically modified tumor vaccines may be able to eradicate or reduce existing tumor deposits to subclinical levels as well as provide long-term protection from regrowth of tumor cells. This report will review and discuss the concept and rationale for the use of cytokine-secreting tumor vaccines for the treatment of human malignancies.

UR - http://www.scopus.com/inward/record.url?scp=0028934301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028934301&partnerID=8YFLogxK

U2 - 10.3109/07357909509011690

DO - 10.3109/07357909509011690

M3 - Article

VL - 13

SP - 193

EP - 201

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 2

ER -